Dow set to soar after a Covid-19 vaccine trial shows promise: July 15, 2020 - CNN

rinwengi.blogspot.com

Moderna, a biotech company, had some much-needed good news to share about coronavirus: Its vaccine candidate has been found to induce immune responses in all of the volunteers who received it in a Phase 1 study.

The stock surged 14% in early trading, and the stock market soared, too.

These early results, published in the New England Journal of Medicine on Tuesday, showed that the vaccine worked to trigger an immune response with mild side effects -- fatigue, chills, headache, muscle pain, pain at the injection site -- becoming the first US vaccine candidate to publish results in a peer-reviewed medical journal.

The vaccine is expected to begin later this month a large Phase 3 trial -- the final trial stage before regulators consider whether to make the vaccine available.

Let's block ads! (Why?)

"stock" - Google News
July 15, 2020 at 06:19PM
https://ift.tt/2WiOG5V

Dow set to soar after a Covid-19 vaccine trial shows promise: July 15, 2020 - CNN
"stock" - Google News
https://ift.tt/37YwtPr
https://ift.tt/3b37xGF

Bagikan Berita Ini